Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-10

FDA Approved: LO LOESTRIN FE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LO LOESTRIN FE from Allergan, Inc. The product is a combination oral contraceptive used for birth control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LO LOESTRIN FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for LO LOESTRIN FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE)